Helicobacter hepaticusDoes Not Induce or Potentiate Colitis in Interleukin-10-Deficient Mice
Open Access
- 1 September 2000
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (9) , 5107-5113
- https://doi.org/10.1128/iai.68.9.5107-5113.2000
Abstract
Helicobacter hepaticushas been reported to induce colitis, hepatitis, and hepatocellular carcinoma in several different murine models. The aim of this study was to determine ifH. hepaticuswill cause colitis in monoassociated mice lacking the interleukin-10 gene (IL-10−/−mice) and potentiate colitis in specific-pathogen-free (SPF) IL-10−/−mice. Germfree IL-10−/−mice on either a mixed (C57BL/6 × 129/Ola) or inbred (129/SvEv) genetic background were monoassociated withH. hepaticusATCC 51448 by oral feeding and rectal enemas. In a second experiment, germfree IL-10−/−mice were colonized with stool from SPF mice that harbored or did not harbor endogenousH. hepaticus. After 7 to 9 weeks of colonization, weight loss and mortality were assessed, the colon was isolated for histology and IL-12 secretion, and mesenteric lymph node cells were assessed for T-cell activation markers. It was found that IL-10−/−mice monoassociated withH. hepaticusfor up to 16 weeks showed almost no histologic colitis or increased IL-12 production. SPF IL-10-knockout mice had no significant difference in weight loss, mortality rate, histologic scores, colonic IL-12 secretion, or T-cell activation with or withoutH. hepaticus. We conclude thatH. hepaticusdoes not induce or potentiate disease in our IL-10−/−mice and therefore is not required to induce colitis in genetically susceptible hosts.Keywords
This publication has 27 references indexed in Scilit:
- Superinfection with helicobacter hepaticus does not alter the natural course of colitis in IL-10 deficient miceGastroenterology, 1998
- Microbial Causation of the Chronic Idiopathic Inflammatory Bowel DiseasesInflammatory Bowel Diseases, 1997
- Enteric Microflora in IBD: Pathogens or Commensals?Inflammatory Bowel Diseases, 1997
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.Journal of Clinical Investigation, 1996
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.The Journal of Experimental Medicine, 1995
- The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.The Journal of Experimental Medicine, 1994
- Chronic Active Hepatitis and Associated Liver Tumors in Mice Caused by a Presistent Bacterial Infection With a Novel Helicobacter SpeciesJNCI Journal of the National Cancer Institute, 1994
- Interleukin-10-deficient mice develop chronic enterocolitisCell, 1993
- Ulcerative colitis-like disease in mice with a disrupted interleukin-2 geneCell, 1993
- The intestinal and serum humoral immune response of mice to systemically and orally administered antigens in liposomes: I. The response to liposome-entrapped soluble proteinsVeterinary Immunology and Immunopathology, 1992